Los Angeles Capital Management LLC Travere Therapeutics, Inc. Transaction History
Los Angeles Capital Management LLC
- $24.2 Billion
- Q4 2024
A detailed history of Los Angeles Capital Management LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 15,996 shares of TVTX stock, worth $328,397. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,996
Previous 27,951
42.77%
Holding current value
$328,397
Previous $391,000
28.9%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding TVTX
# of Institutions
214Shares Held
94.3MCall Options Held
1.2MPut Options Held
778K-
Black Rock Inc. New York, NY7.64MShares$157 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.36MShares$151 Million1.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.74MShares$138 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.97MShares$102 Million3.46% of portfolio
-
Macquarie Group LTD Australia, C34.26MShares$87.4 Million0.09% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.32B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...